Liver transplantation in Jehovah's witnesses: 13 consecutive cases at a single institution.


Journal

BMC anesthesiology
ISSN: 1471-2253
Titre abrégé: BMC Anesthesiol
Pays: England
ID NLM: 100968535

Informations de publication

Date de publication:
30 01 2020
Historique:
received: 29 04 2019
accepted: 16 01 2020
entrez: 1 2 2020
pubmed: 1 2 2020
medline: 26 1 2021
Statut: epublish

Résumé

Jehovah's Witnesses represent a tremendous clinical challenge when indicated to liver transplantation because they refuse blood transfusion on religious grounds and the procedure is historically associated with potential massive peri-operative blood loss. We herein describe a peri-operative management pathway with strategies toward a transfusion-free environment with the aim not only of offering liver transplant to selected Jehovah's Witnesses patients but also, ultimately, of translating this practice to all general surgical procedures. This is a retrospective review of prospective medical records of JW patients who underwent LT at our Institution. The peri-operative multimodal strategy to liver transplantation in Jehovah's Witnesses includes a pre-operative red cell mass optimization package and the intra-operative use of normovolemic haemodilution, veno-venous bypass and low central venous pressure. In a 9-year period, 13 Jehovah's Witness patients received liver transplantation at our centre representing the largest liver transplant program from deceased donors in Jehovah's Witnesses patients reported so far. No patient received blood bank products but 3 had fibrinogen concentrate and one tranexamic acid to correct ongoing hyper-fibrinolysis. There were 4 cases of acute kidney injury (one required extracorporeal renal replacement treatment) and one patient needed vasoactive medications to support blood pressure for the first 2 postoperative days. Two patients underwent re-laparotomy. Finally, of the 13 recipients, 12 were alive at the 1 year follow-up interview and 1 died due to septic complications. Our experience confirms that liver transplantation in selected Jehovah's Witnesses patients can be feasible and safe provided that it is carried out at a very experienced centre and according to a multidisciplinary approach.

Sections du résumé

BACKGROUND
Jehovah's Witnesses represent a tremendous clinical challenge when indicated to liver transplantation because they refuse blood transfusion on religious grounds and the procedure is historically associated with potential massive peri-operative blood loss. We herein describe a peri-operative management pathway with strategies toward a transfusion-free environment with the aim not only of offering liver transplant to selected Jehovah's Witnesses patients but also, ultimately, of translating this practice to all general surgical procedures.
METHODS
This is a retrospective review of prospective medical records of JW patients who underwent LT at our Institution. The peri-operative multimodal strategy to liver transplantation in Jehovah's Witnesses includes a pre-operative red cell mass optimization package and the intra-operative use of normovolemic haemodilution, veno-venous bypass and low central venous pressure.
RESULTS
In a 9-year period, 13 Jehovah's Witness patients received liver transplantation at our centre representing the largest liver transplant program from deceased donors in Jehovah's Witnesses patients reported so far. No patient received blood bank products but 3 had fibrinogen concentrate and one tranexamic acid to correct ongoing hyper-fibrinolysis. There were 4 cases of acute kidney injury (one required extracorporeal renal replacement treatment) and one patient needed vasoactive medications to support blood pressure for the first 2 postoperative days. Two patients underwent re-laparotomy. Finally, of the 13 recipients, 12 were alive at the 1 year follow-up interview and 1 died due to septic complications.
CONCLUSIONS
Our experience confirms that liver transplantation in selected Jehovah's Witnesses patients can be feasible and safe provided that it is carried out at a very experienced centre and according to a multidisciplinary approach.

Identifiants

pubmed: 32000668
doi: 10.1186/s12871-020-0945-x
pii: 10.1186/s12871-020-0945-x
pmc: PMC6993414
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

31

Références

Br J Anaesth. 2010 Oct;105(4):401-16
pubmed: 20802228
Anaesthesia. 2018 Sep;73(9):1141-1150
pubmed: 29989144
Eur J Anaesthesiol. 2005 Aug;22(8):584-90
pubmed: 16119594
Arch Surg. 1994 May;129(5):528-32; discussion 532-3
pubmed: 8185476
Liver Transpl. 2006 Jan;12(1):117-23
pubmed: 16382461
World J Hepatol. 2013 Jan 27;5(1):1-15
pubmed: 23383361
Prog Transplant. 2018 Jun;28(2):116-123
pubmed: 29558874
N Engl J Med. 2007 Sep 6;357(10):965-76
pubmed: 17804841
Curr Opin Organ Transplant. 2011 Jun;16(3):326-30
pubmed: 21505338
World J Transplant. 2015 Dec 24;5(4):165-82
pubmed: 26722645
Blood Transfus. 2017 Jan;15(1):53-56
pubmed: 27136440
J Am Coll Surg. 2005 Sep;201(3):412-7
pubmed: 16125075
Med J Aust. 2007 Aug 6;187(3):188-9
pubmed: 17680750
Anesth Analg. 2014 Feb;118(2):428-37
pubmed: 24445640
Hepatology. 2001 Feb;33(2):464-70
pubmed: 11172350
World J Transplant. 2016 Jun 24;6(2):291-305
pubmed: 27358774
Liver Int. 2018 Feb;38 Suppl 1:134-138
pubmed: 29427483
Arq Gastroenterol. 2013 Apr;50(2):138-40
pubmed: 23903624
Br J Anaesth. 2015 Nov;115(5):676-87
pubmed: 26068896
World J Gastrointest Surg. 2019 Jan 27;11(1):11-18
pubmed: 30705735
Korean J Anesthesiol. 2017 Jun;70(3):350-355
pubmed: 28580088
Transpl Int. 2005 Aug;18(8):929-36
pubmed: 16008742
Liver Transpl. 2005 Jul;11(7):741-9
pubmed: 15973707
Semin Intervent Radiol. 2018 Aug;35(3):153-159
pubmed: 30087517
Vox Sang. 2018 May 1;:null
pubmed: 29714029
Semin Thromb Hemost. 2015 Jul;41(5):538-46
pubmed: 26080304
Minerva Anestesiol. 2018 Mar;84(3):378-388
pubmed: 29027774
Transplant Proc. 2004 Apr;36(3):499-501
pubmed: 15110571

Auteurs

Diego Costanzo (D)

Transplant Anesthesia and Critical Care Unit, University School of Medicine, Azienda Ospedaliera-Universitaria Pisana, Pisa, Italy.

Maria Bindi (M)

Transplant Anesthesia and Critical Care Unit, University School of Medicine, Azienda Ospedaliera-Universitaria Pisana, Pisa, Italy.

Davide Ghinolfi (D)

Liver Transplant Surgery Unit, University School of Medicine, Azienda Ospedaliera-Universitaria Pisana, Pisa, Italy.

Massimo Esposito (M)

Transplant Anesthesia and Critical Care Unit, University School of Medicine, Azienda Ospedaliera-Universitaria Pisana, Pisa, Italy.

Francesco Corradi (F)

Transplant Anesthesia and Critical Care Unit, University School of Medicine, Azienda Ospedaliera-Universitaria Pisana, Pisa, Italy.

Francesco Forfori (F)

Transplant Anesthesia and Critical Care Unit, University School of Medicine, Azienda Ospedaliera-Universitaria Pisana, Pisa, Italy.

Paolo De Simone (P)

Liver Transplant Surgery Unit, University School of Medicine, Azienda Ospedaliera-Universitaria Pisana, Pisa, Italy.

Andrea De Gasperi (A)

Anesthesia and Critical Care Unit, Ospedale Niguarda Ca' Granda, Milan, Italy.

Gianni Biancofiore (G)

Transplant Anesthesia and Critical Care Unit, University School of Medicine, Azienda Ospedaliera-Universitaria Pisana, Pisa, Italy. g.biancofiore@med.unipi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH